Pharmathen Overview

  • Year Founded
  • 1969

Year Founded

  • Status
  • Private

  • Employees
  • 1,300


  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 8

  • Investments
  • 1

Pharmathen General Information


Developer of generic drugs and formulas intended to support improved patient compliance. The company operates as a research-centered, pharmaceutical company that manufactures products like sublingual tablets, hard capsules, eye drops and ophthalmic services, thereby serving in Europe, North America, South America, the Middle East, Asia, Australasia and Southern Africa with new technology platforms and provide optimized pharmaceutical products to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Corporate Office
  • 9, Van Heuven Goedhartlaan
  • 1181 LE Amstelveen
  • Netherlands
+31 020 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmathen Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmathen‘s full profile, request access.

Request a free trial

Pharmathen Comparisons

HQ Location
Total Raised
Post Valuation
Developer of generic drugs and formulas intended to support improved patient compliance. The company operates as a resea
Amstelveen, Netherlands
1,300 As of 2023
000000000 000.00


d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
Mumbai, India
00000 As of 0000
0000 0000-00-00


lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
Pallíni, Greece
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmathen Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 0&0
Alvion Pharmaceuticals Corporation Pallíni, Greece 00
Par Pharmaceutical Companies Formerly PE-Backed Ramapo, NY 0000 00.000 0000000000.
Glenmark Corporation Mumbai, India 00000 00000 000000000 00000
Synthon International Holding Private Equity-Backed Nijmegen, Netherlands 0000 00000 000000000 00 00000
You’re viewing 5 of 27 competitors. Get the full list »

Pharmathen Patents

Pharmathen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2613656-A Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof Pending 13-Dec-2021 0000000000 0
GB-2612779-A Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use Pending 10-Nov-2021 0000000000 0
EP-4262759-A1 Immediate release solid dosage form comprising teriflunomide and method of preparation thereof Pending 15-Dec-2020 0000000000
EP-4213937-A1 Solid dosage form comprising sitagliptin and method of preparation thereof Pending 15-Sep-2020 0000000000
US-20230277417-A1 Process and apparatus for preparing viscous pharmaceutical formulations Pending 07-Aug-2020 A61J3/00
To view Pharmathen’s complete patent history, request access »

Pharmathen Executive Team (8)

Name Title Board Seat Contact Info
Dimitris Kadis Group Chief Executive Officer
Evangelos Karavas Ph.D Chief Scientific Officer, Vice President, Research & Industrial Operations and Vice President of the Board of Directors
Diomedes Vassiliou Group Chief Financial Officer
Nikos Stathopoulos Chief Operations Officer
Andreas Kopp Chief Supply Chain Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Pharmathen Board Members (3)

Name Representing Role Since
00000 000000 VNK Capital Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Pharmathen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmathen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmathen‘s full profile, request access.

Request a free trial

Pharmathen Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Chemical & Biopharmaceutical Laboratories Patras 06-Nov-2023 0000000000 000.00 Pharmaceuticals 00000000
To view Pharmathen’s complete investments history, request access »

Pharmathen Subsidiaries (1)

Company Name Industry Location Founded
Chemical & Biopharmaceutical Laboratories Patras Pharmaceuticals Patras, Greece 0000
To view Pharmathen’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »